KCM
BIIB icon

Kendall Capital Management’s Biogen BIIB Stock Holding History

Kendall Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-750
Closed -$200K – 183
2022
Q3 		$200K Buy
+750
New +$159K 0.12% 166
2022
Q1 		– Sell
-940
Closed -$226K – 163
2021
Q4 		$226K Sell
940
-475
-34% -$122K 0.11% 157
2021
Q3 		$400K Sell
1,415
-210
-13% -$68.8K 0.22% 109
2021
Q2 		$563K Sell
1,625
-50
-3% -$15.1K 0.32% 90
2021
Q1 		$469K Buy
1,675
+40
+2% +$10.8K 0.29% 92
2020
Q4 		$400K Buy
1,635
+145
+10% +$37.4K 0.29% 92
2020
Q3 		$423K Buy
+1,490
New +$416K 0.37% 75

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Kendall Capital Management's BIIB Position: Q4 2022 in Review

Kendall Capital Management sold out of Biogen (BIIB) in Q4 2022, closing a stake of 750 shares — an estimated $200K sold.

Kendall Capital Management first reported a position in BIIB in Q3 2020 and held it in 7 quarters. The position peaked at $563K in Q2 2021. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Kendall Capital Management reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Kendall Capital Management sold 750 Biogen shares in Q4 2022, an estimated $200K.
  • Kendall Capital Management first reported a position in Biogen in Q3 2020 and held it in 7 quarters.
  • Kendall Capital Management's Biogen position peaked at $563K in Q2 2021.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Kendall Capital Management's 13F filing for Q4 2022, filed 30 Jan 2023.